loading...| Preferred Name |
Mitoxantrone |
|
| Synonyms |
|
|
| ID |
http://scai.fraunhofer.de/MSOntology#Mitoxantrone |
|
| Context |
Drug : DBA001193 |
|
| isDefinedBy |
An anthracenedione-derived antineoplastic agent. (MeSH definition ) |
|
| prefixIRI |
MSOntology:Mitoxantrone |
|
| prefLabel |
Mitoxantrone |
|
| Synonym |
NSC 299195 Lederle Brand of Mitoxantrone Hydrochloride Baxter Oncology Brand of Mitoxantrone Hydrochloride NSC-301739D NSC-299195 Novantrone NSC 279836 NSC301739D Wyeth Brand of Mitoxantrone Hydrochloride NSC 287836 AHP Brand of Mitoxantrone Hydrochloride Mitoxantrone Hydrochloride NSC-287836 NSC-279836 Mitoxantrone Acetate NSC 301739 Acetate, Mitoxantrone Mitozantrone Amgen Brand of Mitoxantrone Hydrochloride Hydrochloride, Mitoxantrone Columbia Brand of Mitoxantrone Hydrochloride NSC 301739D ASTA Medica Brand of Mitoxantrone Hydrochloride NSC-301739 Inibsa Brand of Mitoxantrone Hydrochloride Dihydroxyanthracenedione C0026259 DHAD CL 232325 CL-232325 CL232325 DHAQ Mitroxone NSC279836 NSC287836 NSC299195 NSC301739 Novantron Onkotrone Pralifan Ralenova |
|
| subClassOf |
http://scai.fraunhofer.de/MSOntology#Disease_modifying_drugs |